tirzepatide uk nhs first country in Europe to reimburse Tirzepatide (Mounjaro) approved for type
Description
The Rebound Effect One of the most widely reported outcomes of discontinuing GLP-1 and GIP receptor agonists like tirzepatide is significant weight regain
Claussnitzer et al
When we eat food, our gut releases a hormone that helps the body regulate hunger and blood sugar levels
This is a tolerability dose, not a treatment dose for weight loss or HbA1c
Replace the outer needle shield
While its usually not a cause for serious concern, a reaction on your face could indicate that your body is reacting to the medication in an unexpected or undesirable way
